
Faisal Khurshid
Stock Analyst at Jefferies
(4.98)
# 54
Out of 5,184 analysts
254
Total ratings
60.6%
Success rate
65%
Average return
Main Sectors:
Stocks Rated by Faisal Khurshid
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LYCA Lycia Therapeutics | Initiated Coverage: Buy | $50 | $33.07 | +51.19% | 1 | Nov 17, 2026 | |
| YARW Yarrow Bioscience | Initiated Coverage: Buy | $40 | $12.90 | +210.08% | 1 | Nov 15, 2026 | |
| GLUE Monte Rosa Therapeutics | Reiterated: Buy | $25 → $15 | $8.64 | +73.61% | 2 | Nov 5, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterated: Hold | $260 → $250 | $143.82 | +73.83% | 5 | Oct 29, 2026 | |
| EYPT EyePoint | Downgraded: Hold | $8 → $1 | $0.2342 | +326.99% | 3 | Oct 19, 2026 | |
| VCRE Vicore Pharma Holding AB | Initiated Coverage: Buy | $25 | $9.41 | +165.81% | 1 | Oct 9, 2026 | |
| SMMT Summit Therapeutics | Reiterated: Buy | n/a | $9.95 | - | 6 | Sep 29, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $270 | $161.20 | +67.49% | 4 | Sep 3, 2026 | |
| ASND Ascendis Pharma | Reiterated: Buy | $290 → $330 | $252.73 | +30.57% | 3 | Aug 31, 2026 | |
| IMTX Immatics | Rated: Buy | $18 → $17 | $5.77 | +194.63% | 2 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 → $175 | $141.33 | +23.82% | 6 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $333 → $380 | $390.94 | -2.80% | 3 | Jul 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $90 → $158 | $73.20 | +115.85% | 4 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $30 | $29.96 | +0.13% | 2 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $8 | $6.33 | +26.38% | 2 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $76 → $85 | $56.42 | +50.66% | 2 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $37 | $8.72 | +324.31% | 2 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $10.23 | +105.28% | 1 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $103 → $120 | $68.55 | +75.05% | 14 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $55 | $26.72 | +105.88% | 1 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $9.02 | +66.30% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $33 | $26.41 | +24.95% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $94 | $114.63 | -17.99% | 1 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $118 → $110 | $115.31 | -4.60% | 16 | Mar 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $21 | $8.68 | +141.94% | 2 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $142 | $112.36 | +26.38% | 8 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $4 | $9.69 | n/a | 3 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 | $12.85 | n/a | 8 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $29 → $40 | $33.31 | n/a | 11 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 → $9 | $3.85 | n/a | 11 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.82 | n/a | 17 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $14.93 | n/a | 11 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.9305 | n/a | 11 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $13.35 | n/a | 17 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $6.99 | n/a | 13 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $121.40 | n/a | 2 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $93.47 | n/a | 10 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $2 | $4.46 | n/a | 4 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.8707 | n/a | 17 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $4.70 | n/a | 10 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $0.5951 | n/a | 14 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $84.92 | n/a | 1 | Jul 28, 2025 |
Lycia Therapeutics
Nov 17, 2026
Initiated Coverage: Buy
Price Target: $50
Current: $33.07
Upside: +51.19%
Yarrow Bioscience
Nov 15, 2026
Initiated Coverage: Buy
Price Target: $40
Current: $12.90
Upside: +210.08%
Monte Rosa Therapeutics
Nov 5, 2026
Reiterated: Buy
Price Target: $25 → $15
Current: $8.64
Upside: +73.61%
Alnylam Pharmaceuticals
Oct 29, 2026
Reiterated: Hold
Price Target: $260 → $250
Current: $143.82
Upside: +73.83%
EyePoint
Oct 19, 2026
Downgraded: Hold
Price Target: $8 → $1
Current: $0.2342
Upside: +326.99%
Vicore Pharma Holding AB
Oct 9, 2026
Initiated Coverage: Buy
Price Target: $25
Current: $9.41
Upside: +165.81%
Summit Therapeutics
Sep 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.95
Upside: -
Revolution Medicines
Sep 3, 2026
Reiterated: Buy
Price Target: $270
Current: $161.20
Upside: +67.49%
Ascendis Pharma
Aug 31, 2026
Reiterated: Buy
Price Target: $290 → $330
Current: $252.73
Upside: +30.57%
Immatics
Aug 25, 2026
Rated: Buy
Price Target: $18 → $17
Current: $5.77
Upside: +194.63%
Aug 6, 2026
Reiterated: Buy
Price Target: $160 → $175
Current: $141.33
Upside: +23.82%
Jul 12, 2026
Upgraded: Buy
Price Target: $333 → $380
Current: $390.94
Upside: -2.80%
Jul 1, 2026
Upgraded: Buy
Price Target: $90 → $158
Current: $73.20
Upside: +115.85%
Jun 30, 2026
Reiterated: Buy
Price Target: $29 → $30
Current: $29.96
Upside: +0.13%
Jun 23, 2026
Reiterated: Buy
Price Target: $15 → $8
Current: $6.33
Upside: +26.38%
May 27, 2026
Upgraded: Buy
Price Target: $76 → $85
Current: $56.42
Upside: +50.66%
May 1, 2026
Reiterated: Buy
Price Target: $40 → $37
Current: $8.72
Upside: +324.31%
Mar 30, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $10.23
Upside: +105.28%
Mar 25, 2026
Reiterated: Buy
Price Target: $103 → $120
Current: $68.55
Upside: +75.05%
Mar 16, 2026
Initiated Coverage: Buy
Price Target: $55
Current: $26.72
Upside: +105.88%
Mar 15, 2026
Initiated Coverage: Buy
Price Target: $15
Current: $9.02
Upside: +66.30%
Mar 15, 2026
Downgraded: Hold
Price Target: $33
Current: $26.41
Upside: +24.95%
Mar 15, 2026
Downgraded: Hold
Price Target: $94
Current: $114.63
Upside: -17.99%
Mar 15, 2026
Initiated Coverage: Buy
Price Target: $118 → $110
Current: $115.31
Upside: -4.60%
Dec 15, 2025
Reiterated: Buy
Price Target: $20 → $21
Current: $8.68
Upside: +141.94%
Dec 15, 2025
Reiterated: Buy
Price Target: $142
Current: $112.36
Upside: +26.38%
Nov 7, 2025
Downgraded: Hold
Price Target: $5 → $4
Current: $9.69
Upside: n/a
Oct 23, 2025
Reiterated: Hold
Price Target: $12
Current: $12.85
Upside: n/a
Oct 22, 2025
Upgraded: Buy
Price Target: $29 → $40
Current: $33.31
Upside: n/a
Oct 10, 2025
Initiated Coverage: Buy
Price Target: $7 → $9
Current: $3.85
Upside: n/a
Sep 30, 2025
Reiterated: Hold
Price Target: n/a
Current: $3.82
Upside: n/a
Sep 30, 2025
Reiterated: Buy
Price Target: n/a
Current: $14.93
Upside: n/a
Sep 30, 2025
Reiterated: Buy
Price Target: n/a
Current: $0.9305
Upside: n/a
Sep 29, 2025
Reiterated: Buy
Price Target: n/a
Current: $13.35
Upside: n/a
Sep 25, 2025
Reiterated: Buy
Price Target: n/a
Current: $6.99
Upside: n/a
Sep 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $121.40
Upside: n/a
Sep 11, 2025
Reiterated: Buy
Price Target: n/a
Current: $93.47
Upside: n/a
Aug 18, 2025
Reiterated: Buy
Price Target: $4 → $2
Current: $4.46
Upside: n/a
Aug 12, 2025
Reiterated: Buy
Price Target: $3
Current: $0.8707
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $1
Current: $4.70
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $2
Current: $0.5951
Upside: n/a
Jul 28, 2025
Reiterated: Buy
Price Target: n/a
Current: $84.92
Upside: n/a